Acura Pharmaceuticals
ACUR
ACUR was delisted on the 22nd of February, 2017.
22 hedge funds and large institutions have $9.76M invested in Acura Pharmaceuticals in 2015 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 12 closing their positions.
1,500% more call options, than puts
Call options by funds: $16K | Put options by funds: $1K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 6
16% less capital invested
Capital invested by funds: $11.6M → $9.76M (-$1.83M)
19% less funds holding
Funds holding: 27 → 22 (-5)
42% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
+$3.49M |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
+$2.53M |
| 3 |
HCM
Highbridge Capital Management
New York
|
+$146K |
| 4 |
Renaissance Technologies
New York
|
+$45.2K |
| 5 |
SIM
Spark Investment Management
New York
|
+$39.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EWM
Essex Woodlands Management
The Woodlands,
Texas
|
-$61.2K |
| 2 |
California Public Employees Retirement System
Sacramento,
California
|
-$45K |
| 3 |
IB
Intrust Bank
Wichita,
Kansas
|
-$24K |
| 4 |
Charles Schwab
San Francisco,
California
|
-$21K |
| 5 |
CA
Cortland Associates
St Louis,
Missouri
|
-$21K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Goldman Sachs
New York
| – | -$11K | -2,237 | Closed |
|
27
Mariner
Overland Park,
Kansas
| – | -$11K | -2,200 | Closed |
|
28
Bank of New York Mellon
New York
| – | -$11K | -2,158 | Closed |
|
29
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$10K | -2,052 | Closed |
|
30
UBS Group
Zurich,
Switzerland
| – | -$5K | -1,096 | Closed |
|
31
Group One Trading
Chicago,
Illinois
| – | -$3 | -1 | -0.9% |
|
|
PFBT
32
Parkside Financial Bank & Trust
Saint Louis,
Missouri
| – | +$68 | +20 | New |
|
ACUR Hedge Fund Activity: Q3 2015 in Review
22 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Acura Pharmaceuticals (ACUR) for Q3 2015, worth a combined $9.76M — down 16% from $11.6M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of ACUR and 7 opened new positions — a net loss of 5 holders — while 6 trimmed existing stakes and 6 added.
The largest buyer was Deerfield Management, opening a new position worth an estimated $3.49M. The largest seller was Essex Woodlands Management, cutting an estimated $61.2K.
- 22 institutional investors held Acura Pharmaceuticals (ACUR) as of Q3 2015, down from 27 in Q2 2015.
- Funds reported $9.76M of Acura Pharmaceuticals stock for Q3 2015, down 16% quarter-over-quarter.
- 7 funds opened new Acura Pharmaceuticals positions in Q3 2015 and 12 closed out, a net change of -5 holders.
- The largest Acura Pharmaceuticals buyer in Q3 2015 was Deerfield Management, an estimated $3.49M added.
- The largest Acura Pharmaceuticals seller in Q3 2015 was Essex Woodlands Management, an estimated $61.2K sold.
Based on aggregated 13F filings for Q3 2015.